This disparity underscores a critical knowledge gap that must be resolved before confident, evidence-based clinical adoption can be justified
Designed solely for parenteral use (drug administration by intravenous, intramuscular, or subcutaneous injection) following the addition of drugs that require dilution or must be dissolved in an aqueous vehicle prior to injecting
To continue, IGF-1 and IGF-1 binding proteins will be linked to parameters of metabolic syndrome, diabetes, insulin resistance, and obesity
The incretin arms suppress appetite and improve glucose control
Data shown as mean s.d., as analyzed by a two-way repeated ANOVA (time and treatment), with post hoc Tukey Tests for multiple comparisons
The 50mg dosage format provides researchers with the flexibility needed for comprehensive studies while maintaining cost-effectiveness and quality standards